A proposal for immunotherapy of HIV seropositive healthy individuals using an HIV envelope protein devoid of CD4 binding activity.
Van Kuyk
R
R
Department of Pathology, School of Medicine, University of California, Davis 95616.
Luciw
P A
PA
Gardner
M B
MB
D015704:CD4 Antigens / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D015686:Gene Products, env / Q000276:immunology* / Q000378:metabolism; D015699:HIV Envelope Protein gp120 / Q000276:immunology / Q000378:metabolism; D006679:HIV Seropositivity / Q000628:therapy*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D014765:Viral Vaccines / Q000627:therapeutic use*
D015704:CD4 Antigens; D015686:Gene Products, env; D015699:HIV Envelope Protein gp120; D014765:Viral Vaccines